Jesus Cadilla-Martinez

Vigo, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU.

Post-Operative Recurrence of Colonic Crohn's Disease After Colectomy: The RESECOL Study by the Young Group of GETECCU.

Journal: Alimentary pharmacology & therapeutics

Published: January 03, 2026

Effectiveness and safety of dual advanced therapy in inflammatory bowel disease: a multicenter series from Galicia, Spain.

Effectiveness and safety of dual advanced therapy in inflammatory bowel disease: a multicenter series from Galicia, Spain.

Journal: Revista espanola de enfermedades digestivas

Published: September 29, 2025

Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.

Journal: Alimentary pharmacology & therapeutics

Published: June 09, 2024

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

Journal: The American journal of gastroenterology

Published: July 13, 2022

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.

Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.

Journal: Journal of clinical medicine

Published: June 10, 2022

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.

Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.

Journal: Inflammatory bowel diseases

Published: September 10, 2021

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu.

Journal: Journal of clinical medicine

Published: September 07, 2021

Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area.

Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of the Epi-IBD 2011 study in the Vigo area.

Journal: Revista espanola de enfermedades digestivas

Published: June 22, 2021

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.

Journal: Journal of Crohn's & colitis

Published: September 24, 2020

Increased risk of thiopurine-related adverse events in elderly patients with IBD.

Increased risk of thiopurine-related adverse events in elderly patients with IBD.

Journal: Alimentary pharmacology & therapeutics

Published: April 23, 2019

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.

Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study.

Journal: European journal of gastroenterology & hepatology

Published: August 23, 2018

Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.

Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.

Journal: The American journal of gastroenterology

Published: September 07, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026